Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Tesser (NPI 1427049220)

Field	Value
Entity Type	Individual
Organization	John Tesser
Address	9520 W Palm Ln Ste 220
City	Phoenix
State	AZ
ZIP	85037
Taxonomy	Rheumatology Physician
NPI Enumerated	October 31, 2005

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

Total Medicare revenue: $3M and Total Medicaid revenue: none (no Medicaid billing on file), so this provider is effectively a Medicare-only biller in the observed data set. The absence of Medicaid activity means analyses of payer mix, revenue risk, or network leverage should treat Medicare as the operative payer for this practice.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 57.8% of this provider's total Medicare revenue. That degree of concentration indicates financial dependence on a small set of biologic/injectable treatments rather than a broad portfolio of low-margin office procedures.

The top revenue-driving codes are therapy-focused biologic injections and infusion services—J0129 (abatacept, 28.1K claims, $956.3K revenue, 32.3% of Medicare revenue), J3262 (tocilizumab, 75.5K claims, $377.4K revenue, 12.7%), and J0897 (denosumab, 20.9K claims, $376.9K revenue, 12.7%). This code mix is consistent with a rheumatology practice operating an infusion/administration capability for biologics and bone-modifying agents rather than a visit-only outpatient clinic.

Competitive standing on key biologics is above typical national volumes for several codes: J0129 ranks #58 of 1221 (95th percentile; notably above typical national volume) and J0897 ranks #264 of 10057 (97th percentile; notably above typical national volume). These ranks position the provider as a high-volume national performer for abatacept and denosumab administration, suggesting regional or niche leadership on those drugs.

E&M and infusion administration volumes show notable outlier and high-percentile behavior: 99214 appears as an extreme outlier (1.2K claims, $110.2K revenue; ranks #6539 of 479517 nationally, 99th percentile), and chemotherapy/infusion administration codes 96413 (841 claims, $82.4K revenue; 98th percentile) and 96401 (758 claims, $40.2K revenue; 97th percentile) are also well above typical volumes. Together these patterns point to a practice that pairs high-complexity office visits with substantial on‑site infusion throughput.

Ancillary diagnostics and osteoporosis monitoring are present at meaningful volumes—80053 CMP (1.2K claims, $12.1K revenue), 77085 DEXA (198 claims, $10.1K revenue), and 82306 vitamin D (342 claims, $9.9K revenue) appear in the top codes. This mix supports the clinical read that the practice manages chronic rheumatologic and bone health conditions with in-house labs and imaging, enabling bundled visit+infusion workflows.

Provider tenure is long-standing: NPI enumerated 2005-10-31 (~21 years ago), indicating an established practice likely with sustained referral relationships and operational experience in delivering infusion-based rheumatology care. This longevity increases the plausibility that reported high volumes reflect stable service capacity rather than recent, transient shifts.

Strategic implications and residual risk: because 57.8% of Medicare revenue is concentrated in a few biologic/infusion codes and the practice reports no Medicaid revenue, its financial performance will be sensitive to Medicare drug administration reimbursement changes and to shifts in biologic prescribing (including biosimilar uptake). While several codes rank notably above typical national volume, other services show only typical participation, so the provider is a dominant performer for select drugs rather than a universally high-volume multi-service operator.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

63 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	28,130	$30	$956.3K
J3262	Injection, tocilizumab, 1 mg	75,480	$10	$377.4K
J0897	Injection, denosumab, 1 mg	20,940	$20	$376.9K
J3111	Injection, romosozumab-aqqg, 1 mg	44,940	$10	$359.5K
J1602	Injection, golimumab, 1 mg, for intravenous use	20,890	$10	$208.9K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	43,200	$1	$172.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,980	$30	$155.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,240	$90	$110.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	840	$100	$82.4K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	760	$50	$40.2K

Showing 1–10 of 63

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 63 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

John Tesser — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

63 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	3	30	14,700	$30	$494.5K
J3262	10	20	74,500	$1	$367.2K
J1602	17	30	24,040	$10	$316.2K
J0717	8	20	36,100	$1	$246.6K
J3111	5	40	19,530	$10	$178.8K
J0897	17	260	2,940	$20	$115.6K
J1745	6	40	2,980	$30	$103.9K
86235	18	20	130	$20	$59.5K
83970	53	130	80	$40	$33K
86480	13	20	110	$60	$27.2K

Showing 1–10 of 63

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Tesser, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arizona Arthritis & Rheumatology Associates P C	AZ	Rheumatology Physician	$0	$11.2M
Nehad Soloman	AZ	Rheumatology Physician	$5.1M	$0
Alexander Hu	AZ	Internal Medicine Physician	$3.8M	$0
Areena Swarup	AZ	Rheumatology Physician	$3.6M	$0
Saima Chohan	AZ	Rheumatology Physician	$3.5M	$0
Nikila Kumar	AZ	Rheumatology Physician	$3M	$0
Daniel Kreutz	AZ	Rheumatology Physician	$2.8M	$0
Mona Amin	AZ	Rheumatology Physician	$2.7M	$0
Joonhee Lim	AZ	Rheumatology Physician	$2.3M	$0
Andrew Sharobeem	AZ	Rheumatology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as John Tesser, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Banner Estrella Medical Center	AZ	General Acute Care Hospital	$0	$108M
Therapy Tree, PLLC	AZ	Hearing and Speech Clinic/Center	$0	$54.6M
Desert Valley Pediatrics	AZ	Pediatrics Physician	$0	$21.2M
Pedro Denga	AZ	Contractor	$0	$20.7M
Arizona Surgical Specialists Center, LLC	AZ	Ambulatory Surgical Clinic/Center	$1.4M	$8.1M
Southwest Kidney Davita Dialysis Partners LLC	AZ	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$7.3M
Healthy Life Corporation	AZ	Family Medicine Physician	$0	$6.8M
Clear Vision Ophthalmology PC	AZ	Ophthalmology Physician	$0	$6.3M
Az Pediatric Care	AZ	Primary Care Clinic/Center	$0	$6.3M
Southwest Network, Inc.	AZ	Community/Behavioral Health Agency	$0	$6.1M

John Tesser — Billing Profile & Reimbursement Data

Sign up for John Tesser — Billing Profile & Reimbursement Data policy alerts

John Tesser — Billing Profile & Reimbursement Data

Sign up for John Tesser — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References